965 results on '"Malpica, Anais"'
Search Results
2. SOX17: A Highly Sensitive and Specific Immunomarker for Ovarian and Endometrial Carcinomas
3. Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival
4. Precursors in the ovarian stroma: another pathway to explain the origin of ovarian serous neoplasms
5. Folate Receptor Immunohistochemical Staining and Gynecologic Tumors: Initial Experience With 216 Cases.
6. The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes
7. Peritoneal Mesothelioma—An Update
8. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases
9. Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors
10. TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma
11. Ovarian mucinous neoplasms, intestinal type, in premenopausal patients, develop in abnormal ovaries
12. Gynecological Pathology
13. Low-grade serous ovarian cancer: State of the science
14. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases
15. Malignant Peritoneal Mesothelioma Associated With Endometriosis: A Clinicopathologic Study of 15 Cases
16. Immunohistochemical Loss of DPC4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract
17. Prognostic indicators in ovarian serous borderline tumours
18. Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations
19. Nonneoplastic Diseases of the Vagina
20. Neoplastic Lesions of the Vagina
21. Mesenchymal Lesions of the Vulva and Vagina
22. List of Contributors
23. Malignant Mesothelioma of the Peritoneum in Women: A Clinicopathologic Study of 164 Cases
24. Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature
25. Endometrial cancer recurrence at multiple port sites
26. Effects of Gastrointestinal-Type Chemotherapy in Women With Ovarian Mucinous Carcinoma
27. How to approach the many faces of endometrioid carcinoma
28. A 3-Tier Chemotherapy Response Score for Ovarian/Fallopian Tube/Peritoneal High-grade Serous Carcinoma: Is it Clinically Relevant?
29. Supplementary Data from Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
30. Data from Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
31. Supplementary Protocol from Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
32. Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases
33. Clinical outcomes in patients with isolated serous tubal intraepithelial carcinoma (STIC): A comprehensive review
34. Vascular invasion in uterine sarcomas and its significance. A multi-institutional study
35. Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma
36. The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer
37. Additional file 1 of Integrated multi-omic analysis of low-grade ovarian serous carcinoma collected from short and long-term survivors
38. Supplementary Data from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
39. Supplemental Table 2. Distribution of primary vulvar melanomas with tumor thickness > 4.00 mm reported in literature. from Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases
40. Supplementary Figure from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
41. Data from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
42. Supplemental Figure Legend from Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases
43. Supplementary Table 1. Associations between clinical and histopathologic parameters are metastasis (Fisher's exact tests). from Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases
44. Neoadjuvant Chemotherapy (NACT) in Malignant Peritoneal Mesothelioma (MPeM) treated with Cytoreduction (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC)
45. Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)
46. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists
47. International Society of Gynecological Pathologists (ISGyP) Endometrial Cancer Project: Guidelines From the Special Techniques and Ancillary Studies Group
48. Guidelines to Aid in the Distinction of Endometrial and Endocervical Carcinomas, and the Distinction of Independent Primary Carcinomas of the Endometrium and Adnexa From Metastatic Spread Between These and Other Sites
49. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations
50. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.